Literature DB >> 28482698

Preparing for a new generation of biologic therapies: understanding the development and potential of biosimilar cancer therapeutics.

Bertrand Coiffier1.   

Abstract

Entities:  

Keywords:  biosimilars; oncology; targeted biologic therapies

Year:  2017        PMID： 28482698     DOI： 10.2217/fon-2017-0157

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

1.  Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).

Authors:  Caterina Vacchi; Marcella Visentini; Laura Gragnani; Paolo Fraticelli; Antonio Tavoni; Davide Filippini; Francesco Saccardo; Gianfranco Lauletta; Stefania Colantuono; Fabiola Atzeni; Pietro Pioltelli; Andreina Manfredi; Milvia Casato; Anna Linda Zignego; Giuseppe Monti; Maurizio Pietrogrande; Massimo Galli; Marco Sebastiani
Journal:  Intern Emerg Med       Date:  2020-06-10       Impact factor: 3.397

Review 2.  A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation.

Authors:  Jorge J García; Luis E Raez; Daniel Rosas
Journal:  Transl Lung Cancer Res       Date:  2020-10

3.  Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020.

Authors:  Xinning Tong; Xue Li; Nicole L Pratt; Jodie B Hillen; Tyman Stanford; Michael Ward; Elizabeth E Roughead; Edward Chia-Cheng Lai; Ju-Young Shin; Franco W T Cheng; Kuan Peng; Chak Sing Lau; Wai Keung Leung; Ian C K Wong
Journal:  Lancet Reg Health West Pac       Date:  2022-06-24

Review 4.  Current and future roles of biosimilars in oncology practice.

Authors:  Sofia Konstantinidou; Angeliki Papaspiliou; Eleni Kokkotou
Journal:  Oncol Lett       Date:  2019-11-15       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.